Summary
Seventeen patients received standard treatment with intravenous N-acetylcysteine for 18 episodes of severe poisoning with paracetamol (acetaminophen). The dose of N-acetylcysteine was 150 mg/kg given in 15 min followed by 50 mg/kg in 4 h and 100 mg/kg over the next 16 h. Liver damage was absent or mild on 13 occasions (ALT<500 µ/l) and severe on 5 (ALT>1000 µ/l).
Total plasma N-acetylcysteine was estimated by HPLC. The mean maximum plasma concentration after the initial loading dose was 554 mg/l. Concentrations then fell rapidly and after 12 h a mean steady-state level of about 35 mg/l was maintained. When the infusion was discontinued N-acetylcysteine disappeared with a half-life of 5.7 h. The mean steady-state volume of distribution, AUC, mean residence time and total clearance were 536 ml/kg, 1748 mg·h·l−1, 2.91 h and 3.18 ml·min−1·kg−1. These values are generally consistent with those previously reported with much smaller doses and the disposition of N-acetylcysteine does not appear to be dose-dependent. The elimination of N-acetylcysteine was not impaired in the patients with severe liver damage, and the pharmacokinetic variables and plasma concentrations were similar in patients with and without hepatotoxicity.
The dosage schedule for intravenous N-acetylcysteine should probably be modified since adverse reactions invariably occur early when plasma concentrations are at their highest, and liver damage was prevented just as effectively at the lowest as at the highest Cmax. High initial concentrations of N-acetylcysteine can be avoided with simple alternative regimens based on the kinetic data of this study.
Similar content being viewed by others
References
Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT (1979) Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning. Br Med J 2: 1097–1100
Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH (1988) Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the Multicenter Study. (1976 to 1985) N Engl J Med 319: 1557–1562
Flanagan RJ (1987) The role of acetylcysteine in clinical toxicology. Med Toxicol 2: 93–104
Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EM (1988) Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation 77: 787–794
Lauterburg BH, Corcoran GB, Mitchell JR (1983) Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 71; 980–991
Rodenstein D, De Coster A, Gazzaniga A (1978) Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders. Clin Pharmacokinet 3: 247–254
Borgström L, Kågedal B, Paulsen O (1986) Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 31: 217–222
Olsson B, Johansson M, Gabrielsson J, Bolme P (1988) Pharmacokinetics and bioavailability of reduced and oxidised N-acetylcysteine. Eur J Clin Pharmacol 34: 77–82
Burgunder JM, Varriale A, Lauterburg BH (1989) Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol 36: 127–131
De Carol L, Ghizzi A, Costa A, Longo A, Ventresca GP, Lodola E (1989) Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers. Arzneimittelforschung 39: 382–386
Lewis PA, Woodward AJ, Maddock J (1984) High performance liquid chromatographic assay for N-acetylcysteine in plasma and urine. J Pharm Sci 73: 996–998
Lewis PA, Woodward AJ, Maddock J (1985) Improved method for the determination of N-acetylcysteine in human plasma by high performance liquid chromatography. J Chromatograph 327: 261–267
Holdiness MR, Morgan LR, Gillen LE (1986) High performance liquid chromatographic determination of N-acetylcysteine in human serum following acetaminophen overdosage. J Chromatogr 382: 99–106
Adriaenssens PI, Prescott LF (1978) High performance liquid chromatographic estimation of paracetamol metabolites in plasma. Br J Clin Pharmacol 6: 87–88
Prescott LF, Wright N, Roscoe P, Brown SS (1971) Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1: 519–522
Sheffner AL, Medler EM, Bailey KR, Gallo DG, Mueller AJ, Sarett HP (1966) Metabolic studies with acetylcysteine. Biochem Pharmacol 15: 1523–1535
Cotgreave IA, Berggren M, Jones TW, Dawson J, Moldéus P (1987) Gastrointestinal metabolism of N-acetylcysteine in the rat, including an assay for sulfite in biological systems. Biopharm Drug Dispos 8: 377–386
Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT (1977) Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 2: 432–434
Ho SW-C, Beilin LJ (1983) Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: Report of two cases. Br Med J 287: 876–877
Mant TGK, Tempowski JH, Volans GN, Talbot JCC (1984) Adverse reactions to acetylcysteine and effects of overdose. Br Med J 289: 217–219
Donovan JW, Jarvie D, Prescott LF, Proudfoot AT (1987) Adverse reactions of N-acetylcysteine and their relation to plasma levels. Vet Hum Toxicol 29: 470 (abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prescott, L.F., Donovan, J.W., Jarvie, D.R. et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 37, 501–506 (1989). https://doi.org/10.1007/BF00558131
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558131